Connor, Clark & Lunn Investment Management Ltd. - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q1 2022$6,714,000
-37.8%
212,743
-20.2%
0.03%
-37.7%
Q4 2021$10,787,000
+13.5%
266,543
-2.2%
0.05%
+6.0%
Q3 2021$9,506,000
+28.8%
272,607
+1.4%
0.05%
+31.6%
Q2 2021$7,379,000
+19.9%
268,711
+22.6%
0.04%
+11.8%
Q1 2021$6,153,000
+21.8%
219,125
+12.6%
0.03%
+13.3%
Q4 2020$5,050,000
+242.6%
194,539
+126.2%
0.03%
+200.0%
Q3 2020$1,474,00086,0140.01%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders